Glucocorticoid Impaired the Wound Healing Ability of Endothelial Progenitor Cells by Reducing the Expression of CXCR4 in the PGE2 Pathway

Abstract

Background: Endothelial progenitor cells (EPCs) can be used to treat ischemic disease in cell-based therapy owing to their neovascularization potential. Glucocorticoids (GCs) have been widely used as strong anti-inflammatory reagents. However, despite their beneficial effects, side effects, such as impairing wound healing are commonly reported with GC-based therapy, and the effects of GC therapy on the wound healing function of EPCs are unclear.Methods: In this study, we investigated how GC treatment affects the characteristics and wound healing function of EPCs.Results: We found that GC treatment reduced the proliferative ability of EPCs. In addition, the expression of CXCR4 was dramatically impaired, which suppressed the migration of EPCs. A transplantation study in a flap mouse model revealed that GC-treated EPCs showed a poor homing ability to injured sites and a low activity for recruiting inflammatory cells, which led to wound healing dysfunction. Impairment of prostaglandin E2 (PGE2) synthases, cyclooxygenase (COX2) and microsomal PGE2 synthase 1 (mPEGS1) were identified as being involved in the GC-induced impairment of the CXCR4 expression in EPCs. Treatment with PGE2 rescued the expression of CXCR4 and restored the migration ability of GC-treated EPCs. In addition, the PGE2 signal that activated the PI3K/AKT pathway was identified to be involved in the regulation of CXCR4 in EPCs under the effects of GCs. In addition, similar negative effects of GCs were observed in EPCs under hypoxic conditions. Under hypoxic conditions, GCs independently impaired the PGE2 and HIF2α pathways, which downregulated the expression of CXCR4 in EPCs. Our findings highlighted the influences of GCs on the characteristics and functions of EPCs, suggesting that the use of EPCs for autologous cell transplantation in patients who have used GCs for a long time should be considered carefully.

Type 2 Diabetes Mellitus Induced Paracrine Effects on Breast Cancer Metastasis Through Extracellular Vesicles Derived from Human Mesenchymal Stem Cells

“…The cell apoptotic assay was performed as our previously described method [29]. A total number of 10 6 BCCs were seeded onto 10 cm dishes and cultured in the cultured medium until 80% confluency, and then cells were collected by treatment with trypsin and centrifuged at 1,000 rpm for 5 min.…”

Differential Effects of Low- and High-Dose Dexamethasone on Electrically Induced Damage of the Cultured Organ of Corti

“…Glucocorticoids inhibit the re-uptake of excitotoxic glutamate from the synapse, impair calcium regulation and increase accumulation of oxygen radicals (Stein-Behrens et al 1992 ), thereby inducing excitotoxicity (Roy and Sapolsky 2003 ; Sorrells et al 2014 ) and compromising neuronal survival (Kaufer et al 2004 ). Other potential deleterious effects of glucocorticoids include impaired wound healing (Carolina et al 2018 ).…”

Investigating the potential of the secretome of mesenchymal stem cells derived from sickle cell disease patients

“…The PI3k-AKT pathway, a classical regulator of cell cycle and survival, has been implicated in ischemic conditions [11]. Moreover, activation of the AKT signaling pathway in endothelial-progenitor cells has been linked to wound healing and microvascular regeneration [54]. These findings suggest that the injection of BMSC secretomes from SCD patients could positively affect the local microenvironment, thusly facilitating the proliferation, recruitment and migration of resident endothelial cells in response to chemoattractants, which may reinforce skin regeneration and repair in conditions associated with impaired angiogenesis, e.g.…”